GAIN vs GEMI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GAIN presents a stark contrast between deep value and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades at a significant discount to its Graham Number ($32.61) and Intrinsic Value ($93.22), this valuation is offset by a catastrophic recent earnings trend, including a -633.3% YoY EPS growth. The company maintains a strong dividend yield and ROE, but a critical liquidity risk is evident in the 0.18 current ratio. Overall, the asset is undervalued on a book basis but exhibits high operational risk.
GEMI exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic ROE of -416.47%. While the company shows strong top-line revenue growth of 39.40%, this is completely offset by a negative gross margin (-25.78%) and an operating margin of -183.54%, indicating that the company loses money on every unit of service provided. The stock is in a technical freefall, down over 84% in the last year, and is consistently missing earnings estimates by wide margins.
Compare Another Pair
Related Comparisons
GAIN vs GEMI: Head-to-Head Comparison
This page compares Gladstone Investment Corporation (GAIN) and Gemini Space Station, Inc. (GEMI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.